Luxfer Holdings PLC
NYSE:LXFRIndustrial - Machinery
+$0.51 today
- Market cap
- $464.28M
- Beta
- 1.12
- P/E (TTM)
- 86.4
- EPS (TTM)
- $0.22
- Dividend yield
- 2.76%
Volume 0.58M
Average 0.18M
LXFR Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Luxfer Holdings PLCNYSE: LXFR
Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026
Capital expenditures growth accelerates
Q1 FY2026 capital expenditures of $2M (cash outflow) rose 66.7% year over year, ahead of the -18.3% change in trailing-twelve-month capital expenditures. Sequentially, it fell 36.4% from the prior quarter. Over 3 fiscal years it compounded at -2.0% a year.
Context
- Capital expenditures amounted to 2.0% of revenue in FY2025, down 0.6 pp from a year earlier.
- Capital expenditures grew in size in 2 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +66.7% holds above the trailing-twelve-month pace of -18.3%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (7.8M) USD
- Year-over-year change
- +24.3%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (7.8M) | +24.3% |
| FY2024 | 2024-12-31 | (10.3M) | -9.6% |
| FY2023 | 2023-12-31 | (9.4M) | -13.3% |
| FY2022 | 2022-12-31 | (8.3M) | +8.8% |
| FY2021 | 2021-12-31 | (9.1M) | — |
Capital Expenditures vs competitors
How LXFR compares with its peers on the latest reported figures
- LXFR's LTM Mar 2026 capital expenditures of $8.57M is the 6th largest of the 11 companies compared; the peer median is $12.47M.
- Its year-over-year change of -18.3% is the 6th highest of 11, against a peer median of -21.6%.
- Capital expenditures amounts to 2.3% of revenue for LXFR, versus a peer median of 1.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $43.3M | +23.4% | +14.4% | 2.7% | |
| LTM Mar 2026 | $32.08M | -54.0% | +561.0% | — | |
| LTM Mar 2026 | $19.6M | +61.5% | +8.3% | 2.9% | |
| LTM Mar 2026 | $19.44M | -68.5% | -24.4% | 1.3% | |
| LTM Mar 2026 | $17.8M | +12.7% | +2.8% | 1.1% | |
| LTM Mar 2026 | $8.57M | -18.3% | -2.0% | 2.3% | |
| LTM Mar 2026 | $7.14M | -89.8% | -43.7% | 1.1% | |
| LTM Mar 2026 | $6.97M | +59.2% | +6.9% | 1.6% | |
SBCSBC Medical Group Holdings Incorporated | LTM Mar 2026 | $2.16M | -37.5% | -54.4% | 1.3% |
| LTM Mar 2026 | $1.98M | -5.6% | +24.6% | 2.0% | |
| LTM Mar 2026 | $465.62K | -57.2% | -56.0% | 0.1% | |
| Peer median (excluding LXFR) | $12.47M | -21.6% | +4.8% | 1.3% | |
Competitors are the stored peer set for LXFR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 30M | 32M | (2.6M) | 18.3M | 7.7M |
| Depreciation & Amortization | 15.6M | 18M | 12.7M | 13.4M | 9.9M |
| Deferred Income Tax | (1.6M) | 8.7M | (600K) | 1.1M | 6.2M |
| Stock-Based Compensation | 2.8M | 2.5M | 2.8M | 3.5M | 3.6M |
| Change in Working Capital | (1.2M) | (46.6M) | (8M) | 8.9M | (8.9M) |
| Accounts Receivables | (9.8M) | (25.3M) | 16.6M | (4.3M) | 4.3M |
| Inventory | (15.3M) | (25M) | 16.6M | (4.1M) | (6.7M) |
| Accounts Payables | 11.4M | 21.3M | (19M) | 4.8M | (5.7M) |
| Other Working Capital | 12.5M | (17.6M) | (22.2M) | 12.5M | (800K) |
| Other Non-Cash Items | (19.5M) | 1.3M | 22M | 5.9M | 15.5M |
| Operating Cash Flow | 26.1M | 15.9M | 26.3M | 51.1M | 34M |
| Capital Expenditures | (9.1M) | (8.3M) | (9.4M) | (10.3M) | (7.8M) |
| Acquisitions (Net) | 4.1M | (1M) | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (100K) | 3.6M | (100K) | 7.3M | 2.7M |
| Investing Cash Flow | (5.1M) | (5.7M) | (9.5M) | (3.4M) | (5.1M) |
| Debt Repayment | 6.4M | 24.8M | (10.2M) | (27.2M) | (7.2M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (6.4M) | (11.1M) | (2.7M) | (2.3M) | (3.1M) |
| Dividends Paid | (13.6M) | (14.2M) | (14M) | (14M) | (13.9M) |
| Other Financing Activities | (2.5M) | (1.4M) | (600K) | (500K) | (800K) |
| Financing Cash Flow | (16.1M) | (2M) | (27.5M) | (44M) | (25M) |
| Effect of Forex Changes | 0 | (1.7M) | 400K | 0 | 500K |
| Net Change in Cash | 4.9M | 6.5M | (10.3M) | 3.7M | 4.4M |
| Free Cash Flow | 17M | 7.6M | 16.9M | 40.8M | 26.2M |
Luxfer Holdings PLC
NYSE:LXFR
Intrinsic Alpha fair value
Locked
Current Price
$17.35
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.